John Godwin

John Godwin

Auto-generated profile, based on publicly available information

John Godwin

Department of Biological Sciences, North Carolina State University, Raleigh, NC 27695, USA

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2001 in Hormones and Behavior
Verified
Journal Article
Closed access
KSKatharine Semsar
Katharine Semsar
FKFrederique L.M. Kandel
Frederique L.M. Kandel
JGJohn Godwin
John Godwin

1 March 2012 in Hormones and Behavior
Verified
Journal Article
Closed access
JGJohn Godwin
John Godwin
RTRichmond Thompson
Richmond Thompson

1 September 2003 in Physiology & Behavior
Verified
Journal Article
Closed access
HPH Perreault
H Perreault
KSK Semsar
K Semsar
JGJ Godwin
J Godwin

1 April 2010 in Frontiers in Neuroendocrinology
Verified
Journal Article
Closed access
JGJohn Godwin
John Godwin

24 May 2013 in BMC Genomics
Verified
Journal Article
Open access
PDF file
RWRyan Y Wong
Ryan Y Wong
SOSarah E Oxendine
Sarah E Oxendine
JGJohn Godwin
John Godwin
Stress and anxiety-related behaviors are seen in many organisms. Studies have shown that in humans and other animals, treatment with selective serotonin reuptake inhibitors (e.g. fluoxetine) can reduce anxiety and anxiety-related behaviors. The efficacies and side effects, however, can vary between individuals. Fluoxetine can modulate anxiety in a stereospecific manner or with equal efficacy regardless of stereoisomer depending on the mechanism of action (e.g. serotonergic or GABAergic effects). Zebrafish are an emerging and valuable translational model for understanding human health related issues such as anxiety. In this study we present data showing the behavioral and whole brain transcriptome changes with fluoxetine treatment in wild-derived zebrafish and suggest additional molecular mechanisms of this widely-prescribed drug. We used automated behavioral analyses to assess the effects of racemic and stereoisomeric fluoxetine on male wild-derived zebrafish. Both racemic and the individual isomers of fluoxetine reduced anxiety-related behaviors relative to controls and we did not observe stereospecific fluoxetine effects. Using RNA-sequencing of the whole brain, we identified 411 genes showing differential expression with racemic fluoxetine treatment. Several neuropeptides (neuropeptide Y, isotocin, urocortin 3, prolactin) showed consistent expression patterns with the alleviation of stress and anxiety when anxiety-related behavior was reduced with fluoxetine treatment. With gene ontology and KEGG pathway analyses, we identified lipid and amino acid metabolic processes, and steroid biosynthesis among other terms to be over-enriched. Our results demonstrate that fluoxetine reduces anxiety-related behaviors in wild-derived zebrafish and alters their neurogenomic state. We identify two biological processes, lipid and amino acid metabolic synthesis that characterize differences in the fluoxetine treated fish. Fluoxetine may be acting on several different molecular pathways to reduce anxiety-related behaviors in wild-derived zebrafish. This study provides data that could help identify common molecular mechanisms of fluoxetine action across animal taxa.

5 July 2019 in Science Advances
Verified
Journal Article
Open access
PDF file
ETErica V. Todd
Erica V. Todd
OOOscar Ortega-Recalde
Oscar Ortega-Recalde
HLHui Liu
Hui Liu
MLMelissa S. Lamm
Melissa S. Lamm
KRKim M. Rutherford
Kim M. Rutherford
NGNeil Gemmell
Neil Gemmell
Ovary-to-testis transformation in a sex-changing fish involves transcriptomic and epigenomic reprogramming.